ArticleThe Journal of clinical investigation2021

RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics.

Raie T Bekele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.